A study of recent inspection observations allows for baseline trending and continuous improvement. (The opinions expressed in this article do not necessarily reflect FDA’s position on the matter being discussed.)
Maria Eng
Advertisement
Maria Eng is a behavioral epidemiologist and adjunct professor at Johns Hopkins University. She has a Phar.D. and M.P.H. degrees.
Articles by Maria Eng
Advertisement
Latest Updated Articles
Lessons Learned from FDA Inspections of Foreign API FacilitiesPublished: September 8th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of November 3, 2025
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
4
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
5
